In Brief:
Favorable survival rates and acceptable quality of life scores demonstrate that total pancreatectomy is a justifiable operation when needed in premalignant or malignant pancreatic tumors. Relevant perioperative morbidity and mortality rates, in particular when total pancreatectomy is combined with vascular resections, illustrate that patients need to be properly selected.
